BUY Glenmark PharmaceuticalsAmit Seth

byAmit SethHorizon: BTST9 Jul 2026, 3:29 pm ISTvia CNBC Awaaz.

Entry₹2,267.2Inferred
Target₹2,310
Total upside +1.89% (call closed)
Stop loss₹2,240-1.20% risk
At expiry₹2,283.410 Jul 2026, 3:20 pm
Expired+0.71%

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Sept, 5:54 pm IST
2 supporting0 opposing
Supports the BUY call (2)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·7 Jul · 3d ago

Glenmark Pharmaceuticals Inc., USA has launched Olanzapine for Injection, 10 mg/vial, Single-Dose Vial.

NSE · Press Release·6 Jul · 4d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.